SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-022636
Filing Date
2021-05-03
Accepted
2021-04-30 18:17:01
Documents
69
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 2021Q1 10-Q ccxi-10q_20210331.htm   iXBRL 10-Q 1945016
2 EX-10.1 ccxi-ex101_124.htm EX-10.1 21816
3 EX-31.1 ccxi-ex311_11.htm EX-31.1 9416
4 EX-31.2 ccxi-ex312_6.htm EX-31.2 9362
5 EX-32.1 ccxi-ex321_10.htm EX-32.1 6170
6 EX-32.2 ccxi-ex322_7.htm EX-32.2 6276
  Complete submission text file 0001564590-21-022636.txt   7925703

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20210331.xsd EX-101.SCH 53366
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ccxi-20210331_cal.xml EX-101.CAL 55095
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ccxi-20210331_def.xml EX-101.DEF 134473
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20210331_lab.xml EX-101.LAB 404111
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20210331_pre.xml EX-101.PRE 295719
12 EXTRACTED XBRL INSTANCE DOCUMENT ccxi-10q_20210331_htm.xml XML 1721630
Mailing Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35420 | Film No.: 21880482
SIC: 2834 Pharmaceutical Preparations